Conference
Evaluation of a novel class of sulfonanilides for targeted treatment of multiple myeloma: Dual-mechanism compounds inhibiting HIF1 alpha-signaling and inducing apoptosis
Authors
Hose D; Seckinger A; Goldschmidt H; Meissner T; Leber B; Neben K; Hillengass J; Bertsch U; Janssen B; Klein B
Volume
34
Pagination
pp. 18-18
Publisher
KARGER
Publication Date
September 1, 2011
Conference proceedings
ONKOLOGIE
ISSN
0378-584X